Study Site — Dallas, Texas

Study Site is a clinical research site located in Dallas, Texas, United States 75390.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Study Site has participated in 12 clinical trials.

Therapeutic areas: Factor XIII Deficiency, Primary Immune Deficiency, Type 2 Diabetes.

Sponsors: CSL Behring, Intarcia Therapeutics, Pharvaris Netherlands B.V..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site?

Study Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site conducted?

Study Site has 12 clinical trials on record. Their work covers Factor XIII Deficiency, Primary Immune Deficiency, Type 2 Diabetes.

Is Study Site accredited by Crixeo Health?

Yes — Study Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.